Abstract:The conventional techniques to detect circulating tumour cells (CTCs) are lengthy and the use of centrifugal forces in this technique may cause cell mortality. As the number of CTCs in patients is quite low, the present study aims towards a gentler diagnostic procedure so as not to lose too many CTCs during the sample preparation process. Hence, a Three-Dimensional Microwell dialysis (3D-μDialysis) chip was designed in this study to perform gentle fluorescence-removal process by using dialysis-type flow processes without centrifuging. This leads to a minimum manual handling of CTCs obtained in our study without any contamination. In addition, a rapid staining process which necessitates only about half the time of conventional techniques (35 minutes instead of 90 minutes) is being illustrated by the employment of dialysis process (by dynamically removing water and waste at once) instead of only static diffusion (by statically removing only waste by diffusion). Staining efficiency of our technique is improved over conventional staining because of the flow rate in 3D-μDialysis staining. Moreover, the staining process has been validated with clinical whole blood samples from three TNM stage IV colon cancer patients. The current technique may be termed as "miniature rapid staining and dialysing system".

Author Correction: Rapid Staining of Circulating Tumor Cells in Three-Dimensional Microwell Dialysis (3D-Μdialysis) Chip

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Rapid Staining of Circulating Tumor Cells in Three-Dimensional Microwell Dialysis (3D-μDialysis) Chip

Author Correction: Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction: Continuous inertial microparticle and blood cell separation in straight channels with local microstructures (Lab Chip (2016) 16 (532-542))

Corrigendum: Microfluidic-based human prostate-cancer-on-chip

Correction To: Analysis of Dynamic Molecular Networks for Pancreatic Ductal Adenocarcinoma Progression

Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Author Correction: Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

Author Correction: Unraveling the Roles of CD44/CD24 and ALDH1 As Cancer Stem Cell Markers in Tumorigenesis and Metastasis

Corrigendum: Correction of the Figure. Identification of Adhesion-Associated Extracellular Matrix Component Thrombospondin 3 As a Prognostic Signature for Clear Cell Renal Cell Carcinoma.

Erratum: "Microfluidic approaches for cell-based molecular diagnosis" [Biomicrofluidics, 12, 051501 (2018)]

Erratum: Single-band Upconversion Nanoprobes for Multiplexed Simultaneous in Situ Molecular Mapping of Cancer Biomarkers

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Correction: Three-dimensional Numerical Simulation and Experimental Investigation of Boundary-Driven Streaming in Surface Acoustic Wave Microfluidics

Author Correction: 3D Printing of High-Strength Bioscaffolds for the Synergistic Treatment of Bone Cancer

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]